Immune System Therapeutics

2001

Company Description

Immune System Therapeutics develops monoclonal antibody technologies for the treatment of blood cancers and other blood disorders.

Immune System Therapeutics Ltd (IST) is an unlisted public company limited by shares which was incorporated in Australia in 2001. Their mission is to develop and commercialise Mab technology for the treatment of blood cancers and other blood disorders.

CrunchBase

Edit this page

Add a company to our database

Manufacturer:

Science and Engineering
Formed:

2001
Company Website:

http://www.istl.com.au
Company E-mail:

[email protected]
Company Address:

Level 1, 645 Harris Street

Sydney
Australia
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits

Company Description

Immune System Therapeutics develops monoclonal antibody technologies for the treatment of blood cancers and other blood disorders.

Contact Us

Realtime Web

Donate Now :